Surmodics, Inc. (SRDX)
Nov 19, 2025 - SRDX was delisted (reason: acquired by GTCR affiliate)
42.98
+0.15 (0.35%)
Inactive · Last trade price on Nov 18, 2025
Surmodics Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Net Income | -17.63 | -11.54 | -1.54 | -27.27 | 4.24 | 1.12 |
Depreciation & Amortization | 8.46 | 8.69 | 8.52 | 9.14 | 8.02 | 7.26 |
Stock-Based Compensation | 6.53 | 8.22 | 7.61 | 7.06 | 5.86 | 5.45 |
Other Adjustments | 1.21 | 0.24 | 0.16 | 6.13 | 2.13 | -0.94 |
Change in Receivables | 1.23 | -5.24 | -0.98 | -1.52 | -2.48 | 3.46 |
Changes in Inventories | -0.35 | -0.33 | -3.02 | -5.06 | -0.82 | -1.38 |
Changes in Accounts Payable | 2.68 | -0.23 | -0.18 | 1.61 | 0.26 | -0.48 |
Changes in Accrued Expenses | -1.37 | -0.89 | -1.02 | 0.13 | 1.41 | 1.85 |
Changes in Income Taxes Payable | -0.34 | 1.58 | 3.44 | -1.07 | 0.21 | -1.56 |
Changes in Unearned Revenue | -2.84 | -5.16 | -2.47 | -5.7 | -1.05 | -1.19 |
Changes in Other Operating Activities | 0.91 | 4.9 | - | -0.67 | -2.39 | 0.41 |
Operating Cash Flow | -1.88 | 0.25 | 10.51 | -17.22 | 15.39 | 14.01 |
Operating Cash Flow Growth | - | -97.64% | - | - | 9.84% | 74.30% |
Capital Expenditures | -1.66 | -3.49 | -2.92 | -3.37 | -5.28 | -3.67 |
Purchases of Intangible Assets | - | - | - | - | -1 | - |
Purchases of Investments | - | -25.45 | -3.9 | - | -22.72 | -59.92 |
Proceeds from Sale of Investments | - | 26 | - | 9.6 | 43.32 | 54.52 |
Payments for Business Acquisitions | - | - | - | - | -39.55 | - |
Investing Cash Flow | 5.94 | -2.94 | -6.82 | 6.23 | -25.24 | -9.07 |
Short-Term Debt Issued | - | - | - | - | 10 | - |
Short-Term Debt Repaid | - | - | -10 | - | - | - |
Net Short-Term Debt Issued (Repaid) | - | - | -10 | - | 10 | - |
Long-Term Debt Issued | - | - | 29.66 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | 29.66 | - | - | - |
Issuance of Common Stock | 0.72 | 1.22 | 1.25 | 1.25 | 3.13 | 1.62 |
Repurchase of Common Stock | -1.77 | -1.54 | -0.92 | -1.12 | -2.75 | -2.53 |
Net Common Stock Issued (Repurchased) | -1.05 | -0.32 | 0.33 | 0.13 | 0.38 | -0.92 |
Other Financing Activities | - | -2.63 | -1.59 | -0.5 | -0.15 | -3.73 |
Financing Cash Flow | -2.75 | -2.95 | 18.41 | -0.38 | 10.23 | -4.65 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.67 | 0.34 | 0.32 | -0.79 | -0.01 | 0.13 |
Net Cash Flow | 1.98 | -5.3 | 22.42 | -12.16 | 0.37 | 0.42 |
Beginning Cash & Cash Equivalents | 24.3 | 41.42 | 19 | 31.15 | 30.79 | 30.36 |
Ending Cash & Cash Equivalents | 26.28 | 36.12 | 41.42 | 19 | 31.15 | 30.79 |
Free Cash Flow | -3.55 | -3.24 | 7.6 | -20.59 | 10.11 | 10.34 |
Free Cash Flow Growth | - | - | - | - | -2.21% | 406.81% |
FCF Margin | -2.94% | -2.57% | 5.73% | -20.60% | 9.62% | 10.90% |
Free Cash Flow Per Share | -0.25 | -0.23 | 0.54 | -1.48 | 0.72 | 0.75 |
Levered Free Cash Flow | -12.14 | -6.46 | 20.47 | -32.26 | 14.6 | 2.37 |
Unlevered Free Cash Flow | -9.32 | -3.6 | -0.84 | -31.78 | 4.84 | 2.21 |